Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

137.38
Delayed Data
As of 4:00pm ET
 +1.58 / +1.16%
Today’s Change
95.08
Today|||52-Week Range
149.31
+35.20%
Year-to-Date

Today’s Trading

Previous close135.80
Today’s open135.63
Day’s range135.63 - 138.73
Volume18,865
Average volume (3 months)249,386
Market cap$2.9B
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+38.70%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+51.53%
P/E ratio196.3
Price/Sales19.42
Price/Book8.27

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...-0.40-0.85%
GWPHGW Pharmaceuticals P...+1.66+1.36%
MDCOMedicines Co+0.39+1.43%
CBPOChina Biologic Produ...+0.34+0.45%
Data as of 4:02pm ET, 12/13/2017

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)$1.05
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts